Tesamorelin is a peptide that stimulates the bodys natural release of growth hormone-releasing hormone (GHRH) , which can lead to increased production of growth hormone and IGF-1 within physiological ranges
Prescriptions of the newer anti-hyperglycemic agents continue to stagnate, even among eligible patients [19], which may be related, at least in part, to the uncertainty about the optimal clinical management of T2D
Patients experience comprehensive improvements in metabolic health, physical function, and quality of life that transform their overall wellbeing
Lately, that topic is GLP-1s and drug pricing
For example, the LEADER trial showed that liraglutide reduced MACEs risk by 13%, while the SUSTAIN-6 trial indicated a 26% reduction with semaglutide
Efficacy: We prioritize treatments backed by clinical evidence: All medications demonstrate significant weight loss benefits